Hong Kong stock market anomaly | Biotech Pharmaceutical-B (02616.HK) rises by over 9% again, GIC invests over HK$600 million to increase its stake in the company. Second-generation IO product data will soon be disclosed.

According to the WiseMoney Financial APP, China Resources Pharmaceutical Group Limited-B (02616.HK) rose over 9% again. As of the time of publication, it had risen by 7.37% to 10.35 Hong Kong dollars, with a turnover of 2.01 billion Hong Kong dollars.